Ritchie, Lia v. Novo Nordisk A/S et al
Ritchie, Lia and Lia Ritchie |
Novo Nordisk A/S, Novo Nordisk North America Operations A/S, Novo Nordisk US Holdings Inc., Novo Nordisk US Commercial Holdings Inc., Novo Nordisk Inc., Novo Nordisk Research Center Seattle Inc., Novo Nordisk Pharmaceutical Industries LP and Eli Lilly and Company |
WIW/3:23-CV-00797 |
November 17, 2023 |
Judicial Panel on Multidistrict Litigation |
Stephen L Crocker |
Other |
Docket Report
This docket was last retrieved on January 8, 2024. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 27 CERTIFICATE OF SERVICE (AMENDED) - re: pldg. ( 91 in MDL No. 3094)26 in IAS/4:23-cv-00483, 19 in ID/1:23-cv-00518, 22 in ID/3:23-cv-00511, 22 in ID/4:23-cv-00517, 5 in ILS/3:23-cv-03855, 5 in LAE/2:23-cv-07392, 25 in LAW/2:23-cv-01020, 24 in LAW/2:23-cv-01365, 23 in LAW/2:23-cv-01610, 22 in LAW/2:23-cv-01675, 25 in LAW/2:23-cv-01704, 3 in LAW/2:23-cv-01768, 5 in LAW/2:23-cv-01792, 7 in LAW/3:23-cv-01800, 14 in LAW/5:23-cv-01763, 5 in LAW/6:23-cv-01781, 7 in LAW/6:23-cv-01793, 91 in MDL No. 3094, 25 in MSN/1:23-cv-00166, 22 in MSN/3:23-cv-00446, 5 in MSN/3:23-cv-00481, 6 in MSS/1:23-cv-00372, 5 in MSS/2:23-cv-00202, 5 in MSS/3:23-cv-03175, 22 in NE/4:23-cv-03219, 27 in NYE/2:23-cv-08868, 26 in NYW/6:23-cv-06684, 18 in OKE/6:23-cv-00406, 6 in OKN/4:23-cv-00551, 5 in OKW/5:23-cv-01198, 5 in OKW/5:23-cv-01199, 28 in PAE/2:23-cv-03924, 5 in PAE/2:23-cv-04846, 5 in PAE/2:23-cv-04866, 17 in PAE/2:23-cv-04965, 17 in PAE/2:23-cv-04969, 6 in PAE/2:23-cv-04980, 10 in PAE/2:23-cv-05031, 4 in PAE/2:23-cv-05036, 5 in PAE/2:23-cv-05041, 22 in SD/1:23-cv-01017, 22 in UT/2:23-cv-00844, 24 in WIW/3:23-cv-00797) - Filed by Plaintiffs Robin Kelly, #et al.Jarred Olson, Rebekah King, Sharon Arender, Jaclyn Bjorklund, Jack Joiner, Meredith Hotchkiss, Merlon Latham, Brea Hand, Donna Lou Thomas, Robert McDonald, Lia Ritchie, Leigh Decorde, Rodney Muilenburg, Kizzy Williams, Sandra Truss, Blake McClure, Marliene Salinas, DeLisa R Jones #[Suppress List] (Attachments: #1 Errata Proof of Service) Associated Cases: MDL No. 3094 et al. (Morgan, Timothy) Modified on 1/9/2024 (JC). EDITED EVENT TYPE, ADDED MDL LINK |
Filing 26 NOTICE OF APPEARANCE re: pldg.(26 in IAS/4:23-cv-00483, 19 in ID/1:23-cv-00518, 22 in ID/3:23-cv-00511, 22 in ID/4:23-cv-00517, 5 in ILS/3:23-cv-03855, 5 in LAE/2:23-cv-07392, 25 in LAW/2:23-cv-01020, 24 in LAW/2:23-cv-01365, 23 in LAW/2:23-cv-01610, 22 in LAW/2:23-cv-01675, 25 in LAW/2:23-cv-01704, 3 in LAW/2:23-cv-01768, 5 in LAW/2:23-cv-01792, 7 in LAW/3:23-cv-01800, 14 in LAW/5:23-cv-01763, 5 in LAW/6:23-cv-01781, 7 in LAW/6:23-cv-01793, 91 in MDL No. 3094, 25 in MSN/1:23-cv-00166, 22 in MSN/3:23-cv-00446, 5 in MSN/3:23-cv-00481, 6 in MSS/1:23-cv-00372, 5 in MSS/2:23-cv-00202, 5 in MSS/3:23-cv-03175, 22 in NE/4:23-cv-03219, 27 in NYE/2:23-cv-08868, 26 in NYW/6:23-cv-06684, 18 in OKE/6:23-cv-00406, 6 in OKN/4:23-cv-00551, 5 in OKW/5:23-cv-01198, 5 in OKW/5:23-cv-01199, 28 in PAE/2:23-cv-03924, 5 in PAE/2:23-cv-04846, 5 in PAE/2:23-cv-04866, 17 in PAE/2:23-cv-04965, 17 in PAE/2:23-cv-04969, 6 in PAE/2:23-cv-04980, 10 in PAE/2:23-cv-05031, 4 in PAE/2:23-cv-05036, 5 in PAE/2:23-cv-05041, 22 in SD/1:23-cv-01017, 22 in UT/2:23-cv-00844, 24 in WIW/3:23-cv-00797), ( 57 in MDL No. 3094), ( 45 in MDL No. 3094), ( 1 in MDL No. 3094) Filed by Timothy Michael Morgan on behalf of Plaintiffs Robin Kelly, #et al.Jarred Olson, Rebekah King, Sharon Arender, Jaclyn Bjorklund, Jack Joiner, Meredith Hotchkiss, Merlon Latham, Brea Hand, Donna Lou Thomas, Robert McDonald, Lia Ritchie, Leigh Decorde, Rodney Muilenburg, Kizzy Williams, Sandra Truss, Blake McClure, Marliene Salinas, DeLisa R Jones #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3094 et al. (Morgan, Timothy) Modified on 1/9/2024 (JC). ADDED MDL LINK |
Filing 25 MINUTE ORDER CLOSING BRIEFING re: pldg. ( #1 in MDL No. 3094) Briefing in this matter is now closed. The parties to actions on the motion(s) remain under a duty, pursuant to Pa nel Rules 6.1(f) and 6.2(d), to notify the Clerk of the Panel promptly of potential tag-along actions, as well as any development that moots the motion or fully disposes of any action on the motion. Parties in any potential tag-along action may file an Interested Party response, but must do so promptly, and in any event, no later than the Thursday prior to the hearing session at which the motion for transfer is to be heard by the Panel.Signed by Clerk of the Panel Tiffaney D. Pete on 1/8/2024. Associated Cases: MDL No. 3094 et al. (JC) |
Filing 24 REPLY TO RESPONSE TO MOTION FOR TRANSFER re: pldg. (18 in IAS/4:23-cv-00483, 14 in ID/1:23-cv-00518, 16 in ID/3:23-cv-00511, 16 in ID/4:23-cv-00517, 18 in LAW/2:23-cv-01020, 18 in LAW/2:23-cv-01365, 16 in LAW/2:23-cv-01610, 16 in LAW/2:23-cv-01675, 18 in LAW/2:23-cv-01704, 8 in LAW/5:23-cv-01763, #55 in MDL No. 3094, 17 in MSN/1:23-cv-00166, 16 in MSN/3:23-cv-00446, 16 in NE/4:23-cv-03219, 20 in NYE/2:23-cv-08868, 19 in NYW/6:23-cv-06 684, 10 in OKE/6:23-cv-00406, 19 in PAE/2:23-cv-03924, 10 in PAE/2:23-cv-04965, 10 in PAE/2:23-cv-04969, 16 in SD/1:23-cv-01017, 16 in UT/2:23-cv-00844, 18 in WIW/3:23-cv-00797), (19 in IAS/4:23-cv-00483, 15 in ID/1:23-cv-00518, 17 in ID/3:23-cv-00511, 17 in ID/4:23-cv-00517, 19 in LAW/2:23-cv-01020, 19 in LAW/2:23-cv-01365, 17 in LAW/2:23-cv-01610, 17 in LAW/2:23-cv-01675, 19 in LAW/2:23-cv-01704, 9 in LAW/5:23-cv-01763, #58 in MDL No . 3094, 19 in MSN/1:23-cv-00166, 17 in MSN/3:23-cv-00446, 17 in NE/4:23-cv-03219, 21 in NYE/2:23-cv-08868, 20 in NYW/6:23-cv-06684, 11 in OKE/6:23-cv-00406, 20 in PAE/2:23-cv-03924, 11 in PAE/2:23-cv-04965, 11 in PAE/2:23-cv-04969, 17 in SD/1:23-cv-01017, 17 in UT/2:23-cv-00844, 19 in WIW/3:23-cv-00797), (25 in IAS/4:23-cv-00483, 18 in ID/1:23-cv-00518, 21 in ID/3:23-cv-00511, 21 in ID/4:23-cv-00517, 2 in ILS/3:23-cv-03855, 4 in LAE/2:23-cv-07392, 24 in LAW/2:23-cv-01020, 23 in LAW/2:23-cv-01365, 20 in LAW/2:23-cv-01610, 21 in LAW/2:23-cv-01675, 24 in LAW/2:23-cv-01704, 2 in LAW/2:23-cv-01768, 4 in LAW/2:23-cv-01792, 6 in LAW/3:23-cv-01800, 13 in LAW/5:23-cv-01763, 4 in LAW/6:23-cv-01781, 6 in LAW/6:23-cv-01793, #78 in MDL No. 3094, 24 in MSN/1:23-cv-00166, 21 in MSN/3:23-cv-00446, 4 in MSN/3:23-cv-00481, 5 in MSS/1:23-cv-00372, 4 in MSS/2:23-cv-00202, 4 in MSS/3:23-cv-03175, 21 in NE/4:23-cv-03219, 26 in NYE/2:23-cv-08868, 25 in NYW/6:23-cv-06684, 17 in OKE/6:23-cv-00406, 5 in OKN/4:23-cv-00551, 4 in OKW/5:23-cv-01198, 4 in OKW/5:23-cv-01199, 26 in PAE/2:23-cv-03924, 3 in PAE/2:23-cv-04846, 3 in PAE/2:23-cv-04866, 15 in PAE/2:23-cv-04965, 15 in PAE/2:23-cv-04969, 3 in PAE/2:23-cv-04980, 6 in PAE/2:23-cv-05031, 2 in PAE/2:23-cv-05036, 3 in PAE/2:23-cv-05041, 21 in SD/1:23-cv-01017, 21 in UT/2:23-cv-00844, 23 in WIW/3:23-cv-00797), ( #50 in MDL No. 3094, 18 in PAE/2:23-cv-03924), ( #80 in MDL No. 3094, 27 in PAE/2:23-cv-03924, 4 in PAE/2:23-cv-04846, 4 in PAE/2:23-cv-04866, 5 in PAE/2:23-cv-04980, 4 in PAE/2:23-cv-05041) Filed by Plaintiffs Robin Kelly, #et al.Jarred Olson, Rebekah King, Sharon Arender, Jaclyn Bjorklund, Jack Joiner, Meredith Hotchkiss, Merlon Latham, Brea Hand, Donna Lou Thomas, Robert McDonald, Lia Ritchie, Leigh Decorde, Rodney Muilenburg, Kizzy Williams, Sandra Truss, Blake McClure, Marliene Salinas, DeLisa R Jones #[Suppress List] (Attachments: #1 Exhibit Exhibit List, #2 Exhibit 1- Combined Medi caid Data, #3 Exhibit 2- La SOS - Eli Lilly, #4 Exhibit 3- La SOS - Novo Nordisk, #5 Exhibit 4- Eli Lilly Clinical Trials Lake Charles, #6 Exhibit 5- Novo Nordisk Trial Louisiana, #7 Exhibit 6- F DA Review, #8 Exhibit 7- Novo Bjorklund Stay Brief, #9 Exhibit 8- Brown Civil Cover Sheet, #10 Exhibit 9- Farley Shirley and Geiglein Civil Cover Sheets, #11 Proof of Service) Associated Cases: MDL No. 3094 et al. (Autry, Josh) |
Filing 23 INTERESTED PARTY RESPONSE -- (re: pldg. ( 1 in MDL No. 3094, 58 in MDL No. 3094) ) Filed by Defendant Eli Lilly and Company (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3094 et al. (Watral, Diana) Modified on 1/3/2024 (JC). EDITED EVENT TYPE, ADDED MDL LINK |
Filing 22 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. (18 in IAS/4:23-cv-00483, 16 in ID/3:23-cv-00511, 16 in ID/4:23-cv-00517, 18 in LAW/2:23-cv-01020, 18 in LAW/2:23-cv-01365, 16 in LAW/2:23-cv-01675, 18 in LAW/2:23-cv-01704, 8 in LAW/5:23-cv-01763, 55 in MDL No. 3094, 17 in MSN/1:23-cv-00166, 16 in MSN/3:23-cv-00446, 16 in NE/4:23-cv-03219, 20 in NYE/2:23-cv-08868, 19 in NYW/6:23-cv-06684, 19 in PAE/2:23-cv-03924, 10 in PAE/2:23-cv-04965, 10 in PAE/2:23-cv-04969, 16 in SD/1:23-cv-01017, 16 in UT/2:23-cv-00844, 18 in WIW/3:23-cv-00797), (3 in IAS/4:23-cv-00483, 3 in ID/3:23-cv-00511, 3 in ID/4:23-cv-00517, 3 in LAW/2:23-cv-01020, 5 in LAW/2:23-cv-01365, 3 in LAW/2:23-cv-01675, 3 in LAW/2:23-cv-01704, 8 in MDL No. 3094, 3 in MSN/1:23-cv-00166, 3 in MSN/3:23-cv-00446, 3 in NE/4:23-cv-03219, 3 in NYE/2:23-cv-08868, 3 in NYW/6:23-cv-06684, 3 in PAE/2:23-cv-03924, 3 in SD/1:23-cv-01017, 3 in UT/2:23-cv-00844, 3 in WIW/3:23-cv-00797) Filed by Loren Brown on behalf of Defendants NOVO NORDISK A/S, #et al.NOVO NORDISK INC., NOVO NORDISK NORTH AMERICA OPERATIONS A/S, NOVO NORDISK PHARMACEUTICAL INDUSTRIES LP, NOVO NORDISK RESEARCH CENTER SEATTLE INC., NOVO NORDISK US COMMERCIAL HOLDINGS INC., NOVO NORDISK US HOLDINGS INC., Novo Nordisk Research Center Seattle, Inc., Novo Nordisk US Commercial Holdings Inc., #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3094 et al. (Brown, Loren) Modified on 1/3/2024 (RH). DELETED DUPLICATE PARTIES NAMES |
Filing 21 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. (3 in IAS/4:23-cv-00483, 3 in ID/1:23-cv-00518, 3 in ID/3:23-cv-00511, 3 in ID/4:23-cv-00517, 3 in LAW/2:23-cv-01020, 5 in LAW/2:23-cv-01365, 3 in LAW/2:23-cv-01610, 3 in LAW/2:23-cv-01675, 3 in LAW/2:23-cv-01704, 8 in MDL No. 3094, 3 in MSN/1:23-cv-00166, 3 in MSN/3:23-cv-00446, 3 in NE/4:23-cv-03219, 3 in NYE/2:23-cv-08868, 3 in NYW/6:23-cv-06684, 3 in PAE/2:23-cv-03924, 3 in SD/1:23-cv-01017, 3 in UT/2:23-cv-00844, 3 in WIW/3:23-cv-00797) Filed by Diana M. Watral on behalf of Defendant Eli Lilly & Co Associated Cases: MDL No. 3094 et al. (Watral, Diana) Modified on 1/3/2024 (RH). DELETED DUPLICATE PARTY NAMES |
Filing 20 NOTICE OF PRESENTATION OF ORAL ARGUMENT re: pldg. (3 in IAS/4:23-cv-00483, 3 in ID/1:23-cv-00518, 3 in ID/3:23-cv-00511, 3 in ID/4:23-cv-00517, 3 in LAW/2:23-cv-01020, 5 in LAW/2:23-cv-01365, 3 in LAW/2:23-cv-01610, 3 in LAW/2:23-cv-01675, 3 in LAW/2:23-cv-01704, #8 in MDL No. 3094, 3 in MSN/1:23-cv-00166, 3 in MSN/3:23-cv-00446, 3 in NE/4:23-cv-03219, 3 in NYE/2:23-cv-08868, 3 in NYW/6:23-cv-06684, 3 in PAE/2:23-cv-03924, 3 in SD/1:2 3-cv-01017, 3 in UT/2:23-cv-00844, 3 in WIW/3:23-cv-00797), ( #3 in MDL No. 3094), ( #1 in MDL No. 3094), ( #2 in MDL No. 3094) Filed by Timothy Michael Morgan on behalf of Plaintiffs Robin Kelly, #et al.Jarred Olson, Rebekah King, Sharon Arender, Jaclyn Bjorklund, Jack Joiner, Meredith Hotchkiss, Merlon Latham, Brea Hand, Donna Lou Thomas, Lia Ritchie, Leigh Decorde, Rodney Muilenburg, Sandra Truss, Kizzy Williams, Blake McClure, Marliene Salinas, DeLisa R Jones #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3094 et al. (Morgan, Timothy) |
Filing 19 SEE CORRECTED PLDG. 78 RESPONSE IN OPPOSITION -- (re: pldg. ( 1 in MDL No. 3094 ) ) Filed by Defendant Eli Lilly and Company (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3094, IAS/4:23-cv-00483, ID/1:23-cv-00518, ID/3:23-cv-00511, ID/4:23-cv-00517, LAW/2:23-cv-01020, LAW/2:23-cv-01365, LAW/2:23-cv-01610, LAW/2:23-cv-01675, LAW/2:23-cv-01704, LAW/5:23-cv-01763, MSN/1:23-cv-00166, MSN/3:23-cv-00446, NE/4:23-cv-03219, NYE/2:23-cv-08868, NYW/6:23-cv-06684, OKE/6:23-cv-00406, PAE/2:23-cv-03924, PAE/2:23-cv-04965, PAE/2:23-cv-04969, SD/1:23-cv-01017, UT/2:23-cv-00844, WIW/3:23-cv-00797 (Watral, Diana) Modified on 1/3/2024 (JC). |
Filing 18 RESPONSE IN SUPPORT -- (re: pldg. ( 1 in MDL No. 3094) ) Filed by Defendants NOVO NORDISK A/S, #et al. Novo Nordisk North America Operations A/S, Novo Nordisk US Holdings, Inc., Novo Nordisk US Commercial Holdings, Inc., Novo Nordisk, Inc., Novo Nordisk Research Center Seattle, Inc., and Novo Nordisk Pharmaceutical Industries, LP #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3094, IAS/4:23-cv-00483, ID/1:23-cv-00518, ID/3:23-cv-00511, ID/4:23-cv-00517, LAW/2:23-cv-01020, LAW/2:23-cv-01365, LAW/2:23-cv-01610, LAW/2:23-cv-01675, LAW/2:23-cv-01704, LAW/5:23-cv-01763, MSN/1:23-cv-00166, MSN/3:23-cv-00446, NE/4:23-cv-03219, NYE/2:23-cv-08868, NYW/6:23-cv-06684, OKE/6:23-cv-00406, PAE/2:23-cv-03924, PAE/2:23-cv-04965, PAE/2:23-cv-04969, SD/1:23-cv-01017, UT/2:23-cv-00844, WIW/3:23-cv-00797 (Brown, Loren) Modified on 1/2/2024 (JC).REMOVED DUPLICATE PARTY NAMES |
Filing 17 CERTIFICATE OF SERVICE (AMENDED) re: pldg. - to ( #19 in MDL No. 3094, 10 in IAS/4:23-cv-00483, 12 in ID/1:23-cv-00518, 10 in ID/3:23-cv-00511, 10 in ID/4:23-cv-00517, 12 in LAW/2:23-cv-01020, 12 in LAW/2:23-cv-01365, 12 in LAW/2:23-cv-01610, 10 in LAW/2:23-cv-01675, 10 in LAW/2:23-cv-01704, 10 in MSN/1:23-cv-00166, 10 in MSN/3:23-cv-00446, 10 in NE/4:23-cv-03219, 12 in NYE/2:23-cv-08868, 10 in NYW/6:23-cv-06684, 10 in PAE/2:23-cv-03924, 10 in SD/1:23-cv-01017, 10 in UT/2:23-cv-00844, 12 in WIW/3:23-cv-00797) - Filed by Plaintiffs Robin Kelly, #et al.Lia Ritchie, Rodney Muilenburg, Jarred Olson, Leigh Decorde, Jaclyn Bjorklund, Meredith Hotchkiss, Marliene Salinas, DeLisa R Jones #[Suppress List] Associated Cases: MDL No. 3094 et al. (Morgan, Timothy) Modified on 12/21/2023 (JC). EDITED EVENT TYPE |
Filing 16 CERTIFICATE OF SERVICE (AMENDED) re: pldg. (13 in IAS/4:23-cv-00483, 12 in ID/3:23-cv-00511, 12 in ID/4:23-cv-00517, 14 in LAW/2:23-cv-01020, 14 in LAW/2:23-cv-01365, 12 in LAW/2:23-cv-01675, 12 in LAW/2:23-cv-01704, 29 in MDL No. 3094, 13 in MSN/1:23-cv-00166, 12 in MSN/3:23-cv-00446, 12 in NE/4:23-cv-03219, 14 in NYE/2:23-cv-08868, 14 in NYW/6:23-cv-06684, 13 in PAE/2:23-cv-03924, 12 in SD/1:23-cv-01017, 12 in UT/2:23-cv-00844, 14 in WIW/3:23-cv-00797) Filed by Defendants NOVO NORDISK A/S, #et al. Novo Nordisk North America Operations A/S, Novo Nordisk US Holdings, Inc., Novo Nordisk US Commercial Holdings, Inc., Novo Nordisk, Inc., Novo Nordisk Research Center Seattle, Inc., and Novo Nordisk Pharmaceutical Industries, LP. #[Suppress List] -- Associated Cases: MDL No. 3094, IAS/4:23-cv-00483, ID/3:23-cv-00511, ID/4:23-cv-00517, LAW/2:23-cv-01020, LAW/2:23-cv-01365, LAW/2:23-cv-01675, LAW/2:23-cv-01704, MSN/1:23-cv-00166, MSN/3:23-cv-00446, NE/4:23-cv-03219, NYE/2:23-cv-08868, NYW/6:23-cv-06684, PAE/2:23-cv-03924, SD/1:23-cv-01017, UT/2:23-cv-00844, WIW/3:23-cv-00797 (Brown, Loren) Modified on 12/21/2023 (JC). REMOVED DUPLICATE PARTY NAMES |
Filing 15 CERTIFICATE OF SERVICE (AMENDED) re: pldg. (12 in IAS/4:23-cv-00483, 11 in ID/3:23-cv-00511, 11 in ID/4:23-cv-00517, 13 in LAW/2:23-cv-01020, 13 in LAW/2:23-cv-01365, 11 in LAW/2:23-cv-01675, 11 in LAW/2:23-cv-01704, 28 in MDL No. 3094, 12 in MSN/1:23-cv-00166, 11 in MSN/3:23-cv-00446, 11 in NE/4:23-cv-03219, 13 in NYE/2:23-cv-08868, 13 in NYW/6:23-cv-06684, 12 in PAE/2:23-cv-03924, 11 in SD/1:23-cv-01017, 11 in UT/2:23-cv-00844, 13 in WIW/3:23-cv-00797) Filed by Defendants NOVO NORDISK A/S, #et al. Novo Nordisk North America Operations A/S, Novo Nordisk US Holdings, Inc., Novo Nordisk US Commercial Holdings, Inc., Novo Nordisk, Inc., Novo Nordisk Research Center Seattle, Inc., and Novo Nordisk Pharmaceutical Industries, LP. #[Suppress List] -- Associated Cases: MDL No. 3094, IAS/4:23-cv-00483, ID/3:23-cv-00511, ID/4:23-cv-00517, LAW/2:23-cv-01020, LAW/2:23-cv-01365, LAW/2:23-cv-01675, LAW/2:23-cv-01704, MSN/1:23-cv-00166, MSN/3:23-cv-00446, NE/4:23-cv-03219, NYE/2:23-cv-08868, NYW/6:23-cv-06684, PAE/2:23-cv-03924, SD/1:23-cv-01017, UT/2:23-cv-00844, WIW/3:23-cv-00797 (Brown, Loren) Modified on 12/21/2023 (JC). REMOVED DUPLICATE PARTY NAMES |
Filing 14 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 3094) -- Identifying Corporate Parent No Parent Corp. for Novo Nordisk A/S, Corporate Parent Novo Nordisk A/S for Novo Nordisk North America Operations A/S, Novo Nordisk U S Holdings Inc, Corporate Parent Novo Nordisk US Commercial Holdings Inc for Novo Nordisk Inc, Corporate Parent NOVO NORDISK MANUFACTURING OPERATIONS, INC. for Novo Nordisk Pharmaceutical Industries LP., Corporate Parent Novo Nordisk US Holdings Inc. for Novo Nordisk U S Commercial Holdings Inc, Corporate Parent Novo Nordisk US Research Investment Holdings, Inc. for Novo Nordisk Research Center Seattle Inc. (Attachments: #1 Schedule of Actions, #2 Other Corporate Disclosure and Citizenship Statement, #3 Proof of Service) Associated Cases: MDL No. 3094, IAS/4:23-cv-00483, ID/3:23-cv-00511, ID/4:23-cv-00517, LAW/2:23-cv-01020, LAW/2:23-cv-01365, LAW/2:23-cv-01675, LAW/2:23-cv-01704, MSN/1:23-cv-00166, MSN/3:23-cv-00446, NE/4:23-cv-03219, NYE/2:23-cv-08868, NYW/6:23-cv-06684, PAE/2:23-cv-03924, SD/1:23-cv-01017, UT/2:23-cv-00844, WIW/3:23-cv-00797 (Brown, Loren) Modified on 12/21/2023 (JC). EDITED PARENT CORP, REMOVED DUPLICATE PARTY NAMES |
Filing 13 NOTICE OF APPEARANCE re: pldg.( 1 in MDL No. 3094) Filed by Loren Brown on behalf of Defendants Novo Nordisk A/S, #et al. Novo Nordisk North America Operations A/S, Novo Nordisk US Holdings, Inc., Novo Nordisk US Commercial Holdings, Inc., Novo Nordisk, Inc., Novo Nordisk Research Center Seattle, Inc., and Novo Nordisk Pharmaceutical Industries, LP. #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3094, IAS/4:23-cv-00483, ID/3:23-cv-00511, ID/4:23-cv-00517, LAW/2:23-cv-01020, LAW/2:23-cv-01365, LAW/2:23-cv-01675, LAW/2:23-cv-01704, MSN/1:23-cv-00166, MSN/3:23-cv-00446, NE/4:23-cv-03219, NYE/2:23-cv-08868, NYW/6:23-cv-06684, PAE/2:23-cv-03924, SD/1:23-cv-01017, UT/2:23-cv-00844, WIW/3:23-cv-00797 (Brown, Loren) Modified on 12/20/2023 (JC). REMOVED DUPLICATE PARTY NAMES |
Filing 12 NOTICE OF APPEARANCE re: pldg.( #3 in MDL No. 3094), ( #1 in MDL No. 3094), ( #2 in MDL No. 3094) Filed by Timothy Michael Morgan on behalf of Plaintiffs Robin Kelly, #et al.Lia Ritchie, Rodney Muilenburg, Leigh Decorde, Jarred Olson, Jaclyn Bjorklund, Meredith Hotchkiss, Marliene Salinas, DeLisa R Jones #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3094, IAS/4:23-cv-00483, ID/1:23-cv-00518, ID/3:23-cv-00511, ID/4:23-cv-00517, LAW/2:23-cv-01020, LAW/2:23-cv-01365, LAW/2:23-cv-01610, LAW/2:23-cv-01675, LAW/2:23-cv-01704, MSN/1:23-cv-00166, MSN/3:23-cv-00446, NE/4:23-cv-03219, NYE/2:23-cv-08868, NYW/6:23-cv-06684, PAE/2:23-cv-03924, SD/1:23-cv-01017, UT/2:23-cv-00844, WIW/3:23-cv-00797 (Morgan, Timothy) |
Filing 11 ERRATA - to (5 in IAS/4:23-cv-00483, 7 in ID/1:23-cv-00518, 5 in ID/3:23-cv-00511, 5 in ID/4:23-cv-00517, 7 in LAW/2:23-cv-01020, 7 in LAW/2:23-cv-01365, 7 in LAW/2:23-cv-01610, 5 in LAW/2:23-cv-01675, 5 in LAW/2:23-cv-01704, #14 in MDL No. 3094, 5 in MSN/1:23-cv-00166, 5 in MSN/3:23-cv-00446, 5 in NE/4:23-cv-03219, 7 in NYE/2:23-cv-08868, 5 in NYW/6:23-cv-06684, 1 in OKE/6:23-cv-00406, 5 in PAE/2:23-cv-03924, 1 in PAE/2:23-cv-04965, 1 in PAE/2:23-cv-04969, 5 in SD/1:23-cv-01017, 5 in UT/2:23-cv-00844, 7 in WIW/3:23-cv-00797) - Filed by Plaintiffs Robin Kelly, #et al.Lia Ritchie, Rodney Muilenburg, Leigh Decorde, Jarred Olson, Jaclyn Bjorklund, Meredith Hotchkiss, Marliene Salinas, DeLisa R Jones #[Suppress List] (Attachments: #1 Proof of Service) Associated Cases: MDL No. 3094, IAS/4:23-cv-00483, ID/1:23-cv-00518, ID/3:23-cv-00511, ID/4:23-cv-00517, LAW/2:23-cv-01020, LAW/2:23-cv-01365, LAW/2:23-cv-01610, LAW/2:23-cv-01675, LAW/2:23-cv-01704, MSN/1:23-cv-00166, MSN/3:23-cv-00446, NE/4:23-cv-03219, NYE/2:23-cv-08868, NYW/6:23-cv-06684, OKE/6:23-cv-00406, PAE/2:23-cv-03924, PAE/2:23-cv-04965, PAE/2:23-cv-04969, SD/1:23-cv-01017, UT/2:23-cv-00844, WIW/3:23-cv-00797 (Autry, Josh) |
Filing 10 CERTIFICATE OF SERVICE re: pldg. ( #10 in MDL No. 3094) Filed by Defendant Eli Lilly and Company -- Associated Cases: MDL No. 3094, IAS/4:23-cv-00483, ID/1:23-cv-00518, ID/3:23-cv-0051 1, ID/4:23-cv-00517, LAW/2:23-cv-01020, LAW/2:23-cv-01365, LAW/2:23-cv-01610, LAW/2:23-cv-01675, LAW/2:23-cv-01704, MSN/1:23-cv-00166, MSN/3:23-cv-00446, NE/4:23-cv-03219, NYE/2:23-cv-08868, NYW/6:23-cv-06684, OKE/6:23-cv-00406, PAE/2:23-cv-03924, PAE/2:23-cv-04965, PAE/2:23-cv-04969, SD/1:23-cv-01017, UT/2:23-cv-00844, WIW/3:23-cv-00797 (Watral, Diana) |
Filing 9 CERTIFICATE OF SERVICE re: pldg. ( #9 in MDL No. 3094) Filed by Defendant Eli Lilly & Co -- Associated Cases: MDL No. 3094, IAS/4:23-cv-00483, ID/1:23-cv-00518, ID/3:23-cv-00511, ID/4: 23-cv-00517, LAW/2:23-cv-01020, LAW/2:23-cv-01365, LAW/2:23-cv-01610, LAW/2:23-cv-01675, LAW/2:23-cv-01704, MSN/1:23-cv-00166, MSN/3:23-cv-00446, NE/4:23-cv-03219, NYE/2:23-cv-08868, NYW/6:23-cv-06684, OKE/6:23-cv-00406, PAE/2:23-cv-03924, PAE/2:23-cv-04965, PAE/2:23-cv-04969, SD/1:23-cv-01017, UT/2:23-cv-00844, WIW/3:23-cv-00797 (Watral, Diana) |
Filing 8 ***TEXT ONLY ENTRY***MINUTE ORDER (re: pldg. ( #11 in MDL No. 3094) ) -- Motion of: Defendants Novo Nordisk U.S. Holdings, Inc., et al. for Extension of Ti me to File Response -- GRANTED IN PART TO ALL PARTIES. Responses due on or before 12/29/2023. Reply, if any, due on or before 1/5/2024.No further extensions of time will be granted absent extraordinary circumstances. Signed by Clerk of the Panel Tiffaney D Pete on 12/19/2023. Associated Cases: MDL No. 3094, IAS/4:23-cv-00483, ID/1:23-cv-00518, ID/3:23-cv-00511, ID/4:23-cv-00517, LAW/2:23-cv-01020, LAW/2:23-cv-01365, LAW/2:23-cv-01610, LAW/2:23-cv-01675, LAW/2:23-cv-01704, MSN/1:23-cv-00166, MSN/3:23-cv-00446, NE/4:23-cv-03219, NYE/2:23-cv-08868, NYW/6:23-cv-06684, OKE/6:23-cv-00406, PAE/2:23-cv-03924, PAE/2:23-cv-04965, PAE/2:23-cv-04969, SD/1:23-cv-01017, UT/2:23-cv-00844, WIW/3:23-cv-00797 (DLD) |
Filing 7 RESPONSE TO MOTION FOR EXTENSION OF TIME re: pldg. (4 in IAS/4:23-cv-00483, 6 in ID/1:23-cv-00518, 4 in ID/3:23-cv-00511, 4 in ID/4:23-cv-00517, 6 in LAW/2:23-cv-01020, 6 in LAW/2:23-cv-01365, 6 in LAW/2:23-cv-01610, 4 in LAW/2:23-cv-01675, 4 in LAW/2:23-cv-01704, #11 in MDL No. 3094, 4 in MSN/1:23-cv-00166, 4 in MSN/3:23-cv-00446, 4 in NE/4:23-cv-03219, 6 in NYE/2:23-cv-08868, 4 in NYW/6:23-cv-06684, 4 in PAE/2:23-cv-03924, 4 in SD/1:23-cv-01017, 4 in UT/2:23-cv-00844, 6 in WIW/3:23-cv-00797) Filed by Josh Autry on behalf of Plaintiffs Robin Kelly, #et al.Lia Ritchie, Rodney Muilenburg, Leigh Decorde, Jarred Olson, Jaclyn Bjorklund, Meredith Hotchkiss, Marliene Salinas, DeLisa R Jones #[Suppress List] (Attachments: #1 Proof of Service) Associated Cases: MDL No. 3094, IAS/4:23-cv-00483, ID/1:23-cv-00518, ID/3:23-cv-00511, ID/4:23-cv-00517, LAW/2:23-cv-01020, LAW/2:23-cv-01365, LAW/2:23-cv-01610, LAW/2:23-cv-01675, LAW/2:23-cv-01704, MSN/1:23-cv-00166, MSN/3:23-cv-00446, NE/4:23-cv-03219, NYE/2:23-cv-08868, NYW/6:23-cv-06684, OKE/6:23-cv-00406, PAE/2:23-cv-03924, PAE/2:23-cv-04965, PAE/2:23-cv-04969, SD/1:23-cv-01017, UT/2:23-cv-00844, WIW/3:23-cv-00797 (Autry, Josh) Modified on 12/19/2023 (JC). EDITED EVENT TYPE |
Filing 6 JOINT MOTION FOR EXTENSION OF TIME TO FILE RESPONSE re: pldg. ( 1 in MDL No. 3094) Filed by Diana M. Watral on behalf of Defendants Nordisk US Holdings Inc. #et al. , Novo Nordisk US Commercial Holdings Inc., Novo Nordisk Inc., Novo Nordisk Research Center Seattle, Inc., Novo Nordisk Pharmaceutical Industries, LP and Eli Lilly and Company. #[Suppress List] (Attachments: #1 Schedule of Actions, #2 Proof of Service) Associated Cases: MDL No. 3094, IAS/4:23-cv-00483, ID/1:23-cv-00518, ID/3:23-cv-00511, ID/4:23-cv-00517, LAW/2:23-cv-01020, LAW/2:23-cv-01365, LAW/2:23-cv-01610, LAW/2:23-cv-01675, LAW/2:23-cv-01704, MSN/1:23-cv-00166, MSN/3:23-cv-00446, NE/4:23-cv-03219, NYE/2:23-cv-08868, NYW/6:23-cv-06684, PAE/2:23-cv-03924, SD/1:23-cv-01017, UT/2:23-cv-00844, WIW/3:23-cv-00797 (Watral, Diana) Modified on 12/19/2023 (JC). REMOVED DUPLICATE PARTY NAMES , EDITED EVENT TYPE |
Filing 5 CORPORATE DISCLOSURE STATEMENT re: pldg. ( 1 in MDL No. 3094) -- Identifying Corporate Parent No Parent Corp. for Eli Lilly and Company. (Attachments: #1 Schedule of Actions) Associated Cases: MDL No. 3094, ID/1:23-cv-00518, LAW/2:23-cv-01020, LAW/2:23-cv-01610, NYE/2:23-cv-08868, WIW/3:23-cv-00797 (Watral, Diana) Modified on 12/19/2023 (JC). REMOVED DUPLICATE PARTY NAMES |
Filing 4 NOTICE OF APPEARANCE re: pldg.( 1 in MDL No. 3094) Filed by Diana M. Watral on behalf of Defendant Eli Lilly and Company. (Attachments: #1 Schedule of Actions) Associated Cases: MDL No. 3094, ID/1:23-cv-00518, LAW/2:23-cv-01020, LAW/2:23-cv-01610, NYE/2:23-cv-08868, WIW/3:23-cv-00797 (Watral, Diana) Modified on 12/19/2023 (JC). REMOVED DUPLICATE PARTY NAMES |
Filing 3 HEARING ORDER re: pldg. ( #1 in MDL No. 3094) - SECTION A (DESIGNATED FOR ORAL ARGUMENT) PANEL HEARING set for 1/25/2024 in Santa Barbara, C alifornia. Notices of Presentation or Waiver of Oral Argument due on or before 1/2/2024.#Notice of Presentation or Waiver of Oral Argument form (JPML form 9) can be downloaded from our website.Signed by Judge Karen K. Caldwell, Chair, PANEL ON MULTIDISTRICT LITIGATION, on 12/15/2023. (Attachments: #1 Courthouse Advisory) Associated Cases: MDL No. 3094, IAS/4:23-cv-00483, ID/1:23-cv-00518, ID/3:23-cv-00511, ID/4:23-cv-00517, LAW/2:23-cv-01020, LAW/2:23-cv-01365, LAW/2:23-c v-01610, LAW/2:23-cv-01675, LAW/2:23-cv-01704, MSN/1:23-cv-00166, MSN/3:23-cv-00446, NE/4:23-cv-03219, NYE/2:23-cv-08868, NYW/6:23-cv-06684, PAE/2:23-cv-03924, SD/1:23-cv-01017, UT/2:23-cv-00844, WIW/3:23-cv-00797 (RH) |
Filing 2 ***TEXT ONLY NOTICE***NOTICE OF FILING AND PUBLICATION OF BRIEFING SCHEDULE re: pldg. ( #2 in MDL No. 3094), ( #3 in MDL No. 3094), ( #1 in MDL No. 3094) BRIEFING SCHEDULE IS SET AS FOLLOWS: Notices of Appearance due on or before 12/19/2023. Corporate Disclosure Statements due on or before 12/19/2023. Responses due on or before 12/26/2023. Reply, if any, due on or before 1/2/2024. In their briefs, the parties should address what steps they have taken to pursue alternatives to centralization (including, but not limited to, engaging in informal coordination of discovery and scheduling, and seeking Section 1404 transfer of one or more of the subject cases). #Appearance forms (JPML form 18) and #Corporate Disclosure forms can be downloaded from our website. Important: A Corporate Disclosure Form, if required, must be filed, even if one has previously been filed in this MDL.Please visit the #CM/ECF Filing Guidelines & Forms page of our website for additional information.Attorneys must be registered to file in the JPML. Please visit our website for #Registration Information.Signed by Clerk of the Panel Tiffaney D. Pete on 12/5/2023. Associated Cases: MDL No. 3094, IAS/4:23-cv-00483, ID/1:23-cv-00518, ID/3:23-cv-00511, ID/4:23-cv-00517, LAW/2:23-cv-01020, LAW/2:23-cv-01365, LAW/2:23-cv-01610, LAW/2:23-cv-01675, LAW/2:23-cv-01704, MSN/1:23-cv-00166, MSN/3:23-cv-00446, NE/4:23-cv-03219, NYE/2:23-cv-08868, NYW/6:23-cv-06684, PAE/2:23-cv-03924, SD/1:23-cv-01017, UT/2:23-cv-00844, WIW/3:23-cv-00797 (LH) |
Filing 1 MDL Number 3094 Assigned -- MOTION FOR TRANSFER ACCEPTED FOR FILING re: pldg. ( #2 in Pending No. 38), ( #3 in Pending No. 38), ( #1 in Pending No. 38) Associated Cases: Pending No. 38, IAS/4:23-cv-00483, ID/1:23-cv-00518, ID/3:23-cv-00511, ID/4:23-cv-00517, LAW/2:23-cv-01020, LAW/2:23-cv-01365, LAW/2:23-cv-0161 0, LAW/2:23-cv-01675, LAW/2:23-cv-01704, MSN/1:23-cv-00166, MSN/3:23-cv-00446, NE/4:23-cv-03219, NYE/2:23-cv-08868, NYW/6:23-cv-06684, PAE/2:23-cv-03924, SD/1:23-cv-01017, UT/2:23-cv-00844, WIW/3:23-cv-00797 (LH) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.